Free Trial

Biorestorative Therapies (BRTX) Earnings Date, Estimates & Call Transcripts

Biorestorative Therapies logo
$1.53 +0.02 (+1.32%)
As of 03:48 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Biorestorative Therapies Earnings Summary

Biorestorative Therapies released Q2 2025 earnings on August 12, 2025, reporting an EPS of -$0.30, which beat the consensus estimate of -$0.41 by $0.11. Quarterly revenue was reported to be $0.30 million, below analysts' expectations of $0.34 million. With a trailing EPS of -$1.27, Biorestorative Therapies' earnings are expected to grow next year, from ($1.43) to ($0.86) per share.

Upcoming Q3
Earnings Date
Nov. 11After Market ClosesEstimated
Consensus EPS
(Aug. 12)
-$0.41
Actual EPS
(Aug. 12)
-$0.30 Beat By $0.11
Actual Revenue
(Aug. 12)
$0.30M

Q2 2025 Earnings Resources

BRTX Upcoming Earnings

Biorestorative Therapies' next earnings date is estimated for Tuesday, November 11, 2025, based on past reporting schedules.

Get Biorestorative Therapies Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biorestorative Therapies and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BRTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BRTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Biorestorative Therapies Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.26-$0.26-$0.26
Q2 20251-$0.41-$0.41-$0.41
Q3 20251-$0.38-$0.38-$0.38
Q4 20251-$0.28-$0.28-$0.28

Biorestorative Therapies Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/11/2025
(Estimated)
--------
8/12/2025Q2 2025-$0.41-$0.30+$0.11-$0.30$0.34M$0.30M
5/14/2025Q1 2025-$0.32-$0.56 -$0.24-$0.64$0.38M$0.03M
3/27/2025Q4 2024-$0.27-$0.20+$0.07-$0.20$0.48M$0.50M
11/12/2024--$0.35-$0.13+$0.22-$0.13$0.30M$0.23M
8/13/2024Q2 2024-$0.56-$0.50+$0.06-$0.50$0.03M$0.09M
6/11/2024Q1 2024-$0.51-$0.53 -$0.02-$0.73$0.03M$0.04M
3/29/2024Q4 2023--$0.57--$0.57$0.03M$0.02M
11/13/2023Q3 2023-$0.68-$0.64+$0.04-$0.64$0.03M$0.03M

Biorestorative Therapies Earnings - Frequently Asked Questions

Biorestorative Therapies has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 11th, 2025 based off last year's report dates. Learn more on BRTX's earnings history.

In the previous quarter, Biorestorative Therapies (NASDAQ:BRTX) reported ($0.30) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.41) by $0.11. Learn more on analysts' earnings estimate vs. BRTX's actual earnings.

The conference call for Biorestorative Therapies' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Biorestorative Therapies' latest earnings report can be read online.
Read Transcript

Biorestorative Therapies (NASDAQ:BRTX) has a recorded annual revenue of $400,000.00.

Biorestorative Therapies (NASDAQ:BRTX) has a recorded net income of -$8.98 million. BRTX has generated -$1.27 earnings per share over the last four quarters.

Biorestorative Therapies' earnings are expected to grow from ($1.43) per share to ($0.86) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:BRTX) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners